Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 22

1.

Reverting Metabolic Dysfunction in Cortex and Cerebellum of APP/PS1 Mice, a Model for Alzheimer's Disease by Pioglitazone, a Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) Agonist.

Chang KL, Wong LR, Pee HN, Yang S, Ho PC.

Mol Neurobiol. 2019 Nov;56(11):7267-7283. doi: 10.1007/s12035-019-1586-2. Epub 2019 Apr 23.

PMID:
31016475
2.

A Review on Liquid Chromatography-Tandem Mass Spectrometry Methods for Rapid Quantification of Oncology Drugs.

Wong AL, Xiang X, Ong PS, Mitchell EQY, Syn N, Wee I, Kumar AP, Yong WP, Sethi G, Goh BC, Ho PC, Wang L.

Pharmaceutics. 2018 Nov 8;10(4). pii: E221. doi: 10.3390/pharmaceutics10040221. Review.

3.

A Sensitive Liquid Chromatography-Tandem Mass Spectrometry Method for the Determination of Nimbolide in Mouse Serum: Application to a Preclinical Pharmacokinetics Study.

Wang L, Phan DK, Syn N, Xiang X, Song H, Thuya WL, Yang S, Wong AL, Kumar AP, Yong WP, Sethi G, Ho PC, Goh BC.

Pharmaceutics. 2018 Aug 8;10(3). pii: E123. doi: 10.3390/pharmaceutics10030123.

4.

Evaluating the Relationship between Vancomycin Trough Concentration and 24-Hour Area under the Concentration-Time Curve in Neonates.

Tseng SH, Lim CP, Chen Q, Tang CC, Kong ST, Ho PC.

Antimicrob Agents Chemother. 2018 Mar 27;62(4). pii: e01647-17. doi: 10.1128/AAC.01647-17. Print 2018 Apr.

5.

Pan-HDAC inhibition by panobinostat mediates chemosensitization to carboplatin in non-small cell lung cancer via attenuation of EGFR signaling.

Wang L, Syn NL, Subhash VV, Any Y, Thuya WL, Cheow ESH, Kong L, Yu F, Peethala PC, Wong AL, Laljibhai HJ, Chinnathambi A, Ong PS, Ho PC, Sethi G, Yong WP, Goh BC.

Cancer Lett. 2018 Mar 28;417:152-160. doi: 10.1016/j.canlet.2017.12.030. Epub 2018 Jan 4.

PMID:
29306016
6.

Combined use of irinotecan with histone deacetylase inhibitor belinostat could cause severe toxicity by inhibiting SN-38 glucuronidation via UGT1A1.

Wang L, Chan CEL, Wong AL, Wong FC, Lim SW, Chinnathambi A, Alharbi SA, Lee LS, Soo R, Yong WP, Lee SC, Ho PC, Sethi G, Goh BC.

Oncotarget. 2017 Jun 20;8(25):41572-41581. doi: 10.18632/oncotarget.15017.

7.

UDP-galactose and acetyl-CoA transporters as Plasmodium multidrug resistance genes.

Lim MY, LaMonte G, Lee MCS, Reimer C, Tan BH, Corey V, Tjahjadi BF, Chua A, Nachon M, Wintjens R, Gedeck P, Malleret B, Renia L, Bonamy GMC, Ho PC, Yeung BKS, Chow ED, Lim L, Fidock DA, Diagana TT, Winzeler EA, Bifani P.

Nat Microbiol. 2016 Sep 19;1:16166. doi: 10.1038/nmicrobiol.2016.166.

8.

A novel combinatorial strategy using Seliciclib(®) and Belinostat(®) for eradication of non-small cell lung cancer via apoptosis induction and BID activation.

Ong PS, Wang L, Chia DM, Seah JY, Kong LR, Thuya WL, Chinnathambi A, Lau JY, Wong AL, Yong WP, Yang D, Ho PC, Sethi G, Goh BC.

Cancer Lett. 2016 Oct 10;381(1):49-57. doi: 10.1016/j.canlet.2016.07.023. Epub 2016 Jul 25.

PMID:
27461583
9.

Anticancer properties of nimbolide and pharmacokinetic considerations to accelerate its development.

Wang L, Phan DD, Zhang J, Ong PS, Thuya WL, Soo R, Wong AL, Yong WP, Lee SC, Ho PC, Sethi G, Goh BC.

Oncotarget. 2016 Jul 12;7(28):44790-44802. doi: 10.18632/oncotarget.8316. Review.

10.

UGT1A1 Mediated Drug Interactions and its Clinical Relevance.

Goon CP, Wang LZ, Wong FC, Thuya WL, Ho PC, Goh BC.

Curr Drug Metab. 2016;17(2):100-6. Review.

PMID:
26526830
11.

Garcinol: Current status of its anti-oxidative, anti-inflammatory and anti-cancer effects.

Liu C, Ho PC, Wong FC, Sethi G, Wang LZ, Goh BC.

Cancer Lett. 2015 Jun 28;362(1):8-14. doi: 10.1016/j.canlet.2015.03.019. Epub 2015 Mar 18. Review.

PMID:
25796441
12.

Development of an UPLC-MS/MS method for assaying the enzymatic activity of propionyl coenzyme-A carboxylase.

Damavandi MD, Chan EC, Kraus JP, Ho PC, Kang TS.

Bioanalysis. 2014 Feb;6(3):335-48. doi: 10.4155/bio.13.297.

PMID:
24471954
13.

Antiproliferative activity against MCF-7 breast cancer cells by diamino-triazaspirodiene antifolates.

Ma X, Woon RS, Ho PC, Chui WK.

Chem Biol Drug Des. 2009 Sep;74(3):322-6. doi: 10.1111/j.1747-0285.2009.00860.x.

PMID:
19703036
14.

Mesoporous-silica-coated up-conversion fluorescent nanoparticles for photodynamic therapy.

Qian HS, Guo HC, Ho PC, Mahendran R, Zhang Y.

Small. 2009 Oct;5(20):2285-90. doi: 10.1002/smll.200900692.

PMID:
19598161
15.

Tracking transplanted cells in live animal using upconversion fluorescent nanoparticles.

Idris NM, Li Z, Ye L, Sim EK, Mahendran R, Ho PC, Zhang Y.

Biomaterials. 2009 Oct;30(28):5104-13. doi: 10.1016/j.biomaterials.2009.05.062. Epub 2009 Jun 17.

PMID:
19539368
16.

Comparison of the in vitro and in vivo effects of retinoids either alone or in combination with cisplatin and 5-fluorouracil on tumor development and metastasis of melanoma.

Liu X, Chan SY, Ho PC.

Cancer Chemother Pharmacol. 2008 Dec;63(1):167-74. doi: 10.1007/s00280-008-0763-1. Epub 2008 May 9.

PMID:
18465132
17.

Physicochemical effects of terpenes on organogel for transdermal drug delivery.

Lim PF, Liu XY, Kang L, Ho PC, Chan SY.

Int J Pharm. 2008 Jun 24;358(1-2):102-7. doi: 10.1016/j.ijpharm.2008.02.021. Epub 2008 Mar 4.

PMID:
18406084
18.

A preliminary ecotoxicity study of pharmaceuticals in the marine environment.

Choong AM, Teo SL, Leow JL, Koh HL, Ho PC.

J Toxicol Environ Health A. 2006 Nov;69(21):1959-70.

PMID:
16982534
19.

Limonene GP1/PG organogel as a vehicle in transdermal delivery of haloperidol.

Lim PF, Liu XY, Kang L, Ho PC, Chan YW, Chan SY.

Int J Pharm. 2006 Mar 27;311(1-2):157-64. Epub 2006 Jan 31.

PMID:
16451823
20.

Human multidrug resistance associated protein 4 confers resistance to camptothecins.

Tian Q, Zhang J, Tan TM, Chan E, Duan W, Chan SY, Boelsterli UA, Ho PC, Yang H, Bian JS, Huang M, Zhu YZ, Xiong W, Li X, Zhou S.

Pharm Res. 2005 Nov;22(11):1837-53.

PMID:
16132345

Supplemental Content

Loading ...
Support Center